Patents by Inventor Ryan Robinson

Ryan Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240227025
    Abstract: A high-resolution additive manufacturing system based on a parallel printing method using a spatial light modulator. A method and system for additive manufacturing using a DMD in the laser beam path. The use of a pre-heat laser beam in combination with a build laser beam having a DMD along the build laser beam path.
    Type: Application
    Filed: May 16, 2023
    Publication date: July 11, 2024
    Applicant: Nuburu, Inc.
    Inventors: Adam Paricio-Moreau, Mathew Finuf, Eric Boese, Robert Fritz, Dallen Fletcher, Mark S. Zediker, Ryan Robinson
  • Publication number: 20240131593
    Abstract: A high-resolution additive manufacturing system based on a parallel printing method using a spatial light modulator. A method and system for additive manufacturing using a DMD in the laser beam path. The use of a pre-heat laser beam in combination with a build laser beam having a DMD along the build laser beam path.
    Type: Application
    Filed: May 15, 2023
    Publication date: April 25, 2024
    Applicant: Nuburu, Inc.
    Inventors: Adam Paricio-Moreau, Mathew Finuf, Eric Boese, Robert Fritz, Dallen Fletcher, Mark S. Zediker, Ryan Robinson
  • Patent number: 11524289
    Abstract: Provided herein are compositions and devices for diagnosing and treating a viral infection in a subject and/or detecting a viral nucleic acid in a sample. In one example, a sample is treated in a first chamber and the sample is flowed into a second chamber, where any pathogenic nucleic acid is detected by oligonucleotides that are specific to the pathogen under test. Further, the oligonucleotides comprise a cleavage site for a restriction enzyme in the second chamber, which cleaves oligonucleotide-pathogenic nucleic acid hybrid resulting in the exposure of an enzyme that was being held by the oligonucleotide to its substrate, which generates a colorimetric and/or another visual readout.
    Type: Grant
    Filed: November 30, 2021
    Date of Patent: December 13, 2022
    Assignee: Conduit Inc.
    Inventors: Logan Thrasher Collins, Ryan Robinson
  • Publication number: 20220168728
    Abstract: Provided herein are compositions, methods, assays, and devices for diagnosing and treating a viral infection in a subject and/or detecting a viral nucleic acid in a sample. In one example, a sample is treated in a first chamber and via a closing or twisting operation, the sample is flowed into a second chamber, where any pathogenic nucleic acid is detected by oligonucleotides that are specific to the pathogen under test. Further, the oligonucleotides comprise are cleavage site for a restriction enzyme in the second chamber, which cleaves oligonucleotide-pathogenic nucleic acid hybrid resulting in the exposure of an enzyme that was being held by the oligonucleotide to its substrate, which generates a colorimetric and/or another visual readout (e.g., foam formation). Further, the methods, device, or kits provided herein can be used to detect SARS-CoV-2 in a saliva sample from a human subject as a rapid in home diagnostic test for COVID-19.
    Type: Application
    Filed: November 30, 2021
    Publication date: June 2, 2022
    Applicant: CONDUIT, INC.
    Inventors: Logan Thrasher COLLINS, Ryan ROBINSON
  • Patent number: D845343
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: April 9, 2019
    Assignee: Sorenson IP Holdings, LLC
    Inventor: Ryan Robinson